{"id":7718,"date":"2021-12-16T10:29:01","date_gmt":"2021-12-16T15:29:01","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/tesamorelin-usan-tesamorelin-cas-218949-48-5-pentru-tratamentul-sindromului-tulburarii-metabolismului-lipidic-asociat-hiv\/"},"modified":"2021-12-16T10:29:01","modified_gmt":"2021-12-16T15:29:01","slug":"tesamorelin-usan-tesamorelin-cas-218949-48-5-pentru-tratamentul-sindromului-tulburarii-metabolismului-lipidic-asociat-hiv","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/ro\/product\/tesamorelin-usan-tesamorelin-cas-218949-48-5-pentru-tratamentul-sindromului-tulburarii-metabolismului-lipidic-asociat-hiv\/","title":{"rendered":"Tesamorelin (usan)\/ Tesamorelin CAS 218949-48-5 Pentru tratamentul sindromului tulbur\u0103rii metabolismului lipidic asociat HIV"},"content":{"rendered":"<h2><strong>Tesamorelin (usan)\/ Tesamorelin CAS 218949-48-5 Pentru tratamentul sindromului tulbur\u0103rii metabolismului lipidic asociat HIV<\/strong><\/h2>\n<p>Nume produs: Tesamorelin (usan)<br \/>\nSinome: D06655;Tesamorelin (usan);TesamorelinAcetate;Peptide farmaceutice v\u00e2ndute foarte bine 2mg Tesamorelin 99%;Tesamorelin (usan) USP\/EP\/BP<br \/>\nCAS: 218949 -5<br \/>\nMF:<br \/>\nMW: 0<br \/>\nEINECS: 603-809-2<br \/>\nCategorii de produse:<br \/>\nFi\u0219ier Mol: Fi\u0219ier Mol<\/p>\n<p>Tesamorelin este o peptid\u0103 sintetic\u0103 const\u00e2nd din to\u021bi cei 44 de aminoacizi ai hGRF cu ad\u0103ugarea unui grup de acid trans-3-hexenoic.Tesamorelin (cunoscut \u0219i sub numele de Egrifta) este o form\u0103 sintetic\u0103 de hormon de eliberare a hormonului de cre\u0219tere care este utilizat \u00een tratamentul lipodistrofiei asociate HIV.tendon. fibroblaste \u00eentr-o manier\u0103 dependent\u0103 de doz\u0103, a\u0219a cum a eviden\u021biat testul de migrare a filtrului transwell. BPC 157 a accelerat, de asemenea, \u00een func\u021bie de doz\u0103, r\u0103sp\u00e2ndirea fibroblastelor de tendon pe vase de cultur\u0103. Formarea de F-actin\u0103, a\u0219a cum a fost detectat\u0103 prin colorarea cu FITC-faloidin\u0103, a fost indus\u0103 \u00een fibroblastele tratate cu BPC 157. Expresia proteinei \u0219i activarea FAK \u0219i a paxilinei au fost determinate prin analiz\u0103 Western blot, iar nivelurile de fosforilare at\u00e2t ale FAK, c\u00e2t \u0219i ale paxilinei au fost crescute \u00een func\u021bie de doz\u0103 de BPC 157, \u00een timp ce cantit\u0103\u021bile totale de protein\u0103 au fost nemodificate. \u00cen concluzie, BPC 157 promoveaz\u0103 cre\u0219terea ex vivo a fibroblastelor de tendon din explantele de tendon, supravie\u021buirea celulelor sub stres \u0219i migrarea in vitro a fibroblastelor de tendon, care este probabil mediat\u0103 de activarea c\u0103ii FAK-paxilin\u0103.<br \/>\n&lt;&amp; &gt; <strong>Aplica\u021bii Tesamorelin<\/strong> <\/p>\n<p>1. Triptorelinul cre\u0219te nivelul de testosteron determin\u00e2nd stimularea constant\u0103 a hipofizarului, scade secre\u021bia hipofizar\u0103 a gonadotropinelor hormonul luteinizant (LH) \u0219i hormonul foliculostimulant (FSH).<\/p>\n<p>2. Ca \u0219i al\u021bi agoni\u0219ti ai GnRH, triptorelina poate fi utilizat\u0103 \u00een tratamentul cancerelor sensibile la hormoni, cum ar fi cancerul de prostat\u0103 sau cancerul de s\u00e2n, pubertatea precoce, afec\u021biunile dependente de estrogen (cum ar fi endometrioza sau fibromul uterin) \u0219i \u00een reproducerea asistat\u0103.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nume produs: Tesamorelin (usan)<br \/>\nCAS: 218949-48-5<br \/>\nEINECS: 603-809-2<br \/>\nMol File: Mol File<\/p>\n","protected":false},"featured_media":2172,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[517],"product_tag":[2065],"class_list":{"0":"post-7718","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-alte-peptide","7":"product_tag-tesamorelin-usan-tesamorelin-cas-218949-48-5-for-the-treatment-of-hiv-associated-lipid-metabolism-disorder-syndrome-ro","8":"desktop-align-left","9":"tablet-align-left","10":"mobile-align-left","12":"first","13":"instock","14":"shipping-taxable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/ro\/wp-json\/wp\/v2\/product\/7718","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/ro\/wp-json\/wp\/v2\/comments?post=7718"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/ro\/wp-json\/wp\/v2\/media\/2172"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/ro\/wp-json\/wp\/v2\/media?parent=7718"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/ro\/wp-json\/wp\/v2\/product_brand?post=7718"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/ro\/wp-json\/wp\/v2\/product_cat?post=7718"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/ro\/wp-json\/wp\/v2\/product_tag?post=7718"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}